Hematological Tumor - Pipeline Review, H1 2014

Hematological Tumor - Pipeline Review, H1 2014 report provides comprehensive information on the therapeutic development for Hematological Tumor, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hematological Tumor and special features on late-stage and discontinued projects.